165 related articles for article (PubMed ID: 20230196)
1. Leptin as a potential therapeutic target for breast cancer prevention and treatment.
Ray A; Cleary MP
Expert Opin Ther Targets; 2010 Apr; 14(4):443-51. PubMed ID: 20230196
[TBL] [Abstract][Full Text] [Related]
2. Effect of obesity on breast cancer development.
Cleary MP; Grossmann ME; Ray A
Vet Pathol; 2010 Mar; 47(2):202-13. PubMed ID: 20124008
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review).
Rose DP; Gilhooly EM; Nixon DW
Int J Oncol; 2002 Dec; 21(6):1285-92. PubMed ID: 12429979
[TBL] [Abstract][Full Text] [Related]
4. Obesity and breast cancer: status of leptin and adiponectin in pathological processes.
Grossmann ME; Ray A; Nkhata KJ; Malakhov DA; Rogozina OP; Dogan S; Cleary MP
Cancer Metastasis Rev; 2010 Dec; 29(4):641-53. PubMed ID: 20821253
[TBL] [Abstract][Full Text] [Related]
5. Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells.
Lautenbach A; Budde A; Wrann CD; Teichmann B; Vieten G; Karl T; Nave H
Nutr Cancer; 2009; 61(4):484-91. PubMed ID: 19838920
[TBL] [Abstract][Full Text] [Related]
6. Obesity hormone leptin: a new target in breast cancer?
Surmacz E
Breast Cancer Res; 2007; 9(1):301. PubMed ID: 17274833
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of leptin and adiponectin in breast cancer.
Jardé T; Perrier S; Vasson MP; Caldefie-Chézet F
Eur J Cancer; 2011 Jan; 47(1):33-43. PubMed ID: 20889333
[TBL] [Abstract][Full Text] [Related]
8. IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines.
Perrier S; Caldefie-Chézet F; Vasson MP
FEBS Lett; 2009 Jan; 583(2):259-65. PubMed ID: 19111549
[TBL] [Abstract][Full Text] [Related]
9. Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention.
Harvie M; Howell A
Obes Rev; 2006 Feb; 7(1):33-47. PubMed ID: 16436101
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives.
Macciò A; Madeddu C; Mantovani G
Obes Rev; 2009 Nov; 10(6):660-70. PubMed ID: 19460113
[TBL] [Abstract][Full Text] [Related]
11. Mammary tumor development from T47-D human breast cancer cells in obese ovariectomized mice with and without estradiol supplements.
Nkhata KJ; Ray A; Dogan S; Grande JP; Cleary MP
Breast Cancer Res Treat; 2009 Mar; 114(1):71-83. PubMed ID: 18392696
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer.
Schäffler A; Schölmerich J; Buechler C
Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):345-54. PubMed ID: 17377617
[TBL] [Abstract][Full Text] [Related]
13. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
Perera CN; Chin HG; Duru N; Camarillo IG
J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
[TBL] [Abstract][Full Text] [Related]
14. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.
Vona-Davis L; Rose DP
Endocr Relat Cancer; 2007 Jun; 14(2):189-206. PubMed ID: 17639037
[TBL] [Abstract][Full Text] [Related]
15. Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer.
Núñez NP; Jelovac D; Macedo L; Berrigan D; Perkins SN; Hursting SD; Barrett JC; Brodie A
Clin Cancer Res; 2004 Aug; 10(16):5375-80. PubMed ID: 15328175
[TBL] [Abstract][Full Text] [Related]
16. Leptin signaling in breast cancer: an overview.
Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N
J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells.
Dos Santos E; Benaitreau D; Dieudonne MN; Leneveu MC; Serazin V; Giudicelli Y; Pecquery R
Oncol Rep; 2008 Oct; 20(4):971-7. PubMed ID: 18813842
[TBL] [Abstract][Full Text] [Related]
18. Weight reduction for breast cancer prevention by restriction of dietary fat and calories: rationale, mechanisms and interventions.
Heber D; McCarthy WJ; Ashley J; Byerley LO
Nutrition; 1989; 5(3):149-54. PubMed ID: 2520282
[TBL] [Abstract][Full Text] [Related]
19. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland.
Snedeker SM; Diaugustine RP
Prog Clin Biol Res; 1996; 394():211-53. PubMed ID: 8778798
[TBL] [Abstract][Full Text] [Related]
20. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
